Dr Harry Hebert
Principal Investigator
Population Health and Genomics, School of Medicine
Contact
Biography
Dr Harry Hebert was appointed as a Tenure Track Principal Investigator (non-clinical), in June 2024 and is based in the Chronic Pain Research Group. Prior to his current post, Harry worked for 8 years as a postdoctoral researcher with Professors Blair H Smith and Lesley Colvin. During this time he worked on the DOLORisk study, in which he developed and validated a socio-demographic risk prediction model for neuropathic pain. In addition to this he led a study assessing the impact of a clinical guideline on the management of chronic pain (SIGN 136) on the prescribing of opioid medications.
Harry holds a PhD in Genetic Epidemiology from the University of Manchester (2014) supervised by Dr Richard Warren, Professor Anne Barton and Dr John Bowes, an MSc in Human Molecular Genetics from Imperial College London (2010) and a BSc(Hons) in Genetics from the University of Nottingham (2009).
Research
Dr Hebert’s current research focusses on the pharmacoepidemiology of chronic (neuropathic) pain including the prevalence and predictors of analgesic use, treatment response, side effects and serious harms (such as overdose and death). He is currently a Principal Investigator on projects exploring the impact of gabapentin and pregabalin (gabapentinoids) reclassification on prescribing and serious harms in the UK, predictors of recommended neuropathic pain medication prescribing and response (PRONE study) and risk factors for adverse outcomes in women and young people with substance use disorder. One of his goals is to improve the lives of people living with chronic pain, by ensuring that clinical guidelines and practice are informed by high quality research.
Research projects
Project lead
Research project
Identifying predictors of neuropathic pain medication prescribing and response in diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy
Research project
Project to look at the pain caused by nerve damage
Project team
Research project
PAINSTORM is a group of research centres from the UK and Belgium. Our aim is to understand the disease processes of NeuP